These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 26753399)

  • 1. [Cell senescence and pathophysiology of chronic lung diseases: role in chronic obstructive pulmonary disease].
    Adnot S
    Bull Acad Natl Med; 2014; 198(4-5):659-71. PubMed ID: 26753399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cellular senescence and pulmonary disease: COPD as an example].
    Boyer L; Savale L; Boczkowski J; Adnot S
    Rev Mal Respir; 2014 Dec; 31(10):893-902. PubMed ID: 25496787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema.
    Chilosi M; Carloni A; Rossi A; Poletti V
    Transl Res; 2013 Sep; 162(3):156-73. PubMed ID: 23831269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF).
    Kuwano K; Araya J; Hara H; Minagawa S; Takasaka N; Ito S; Kobayashi K; Nakayama K
    Respir Investig; 2016 Nov; 54(6):397-406. PubMed ID: 27886850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aging lung and chronic obstructive pulmonary disease: similarity and difference.
    Fukuchi Y
    Proc Am Thorac Soc; 2009 Dec; 6(7):570-2. PubMed ID: 19934351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential.
    Adnot S; Amsellem V; Boyer L; Marcos E; Saker M; Houssaini A; Kebe K; Dagouassat M; Lipskaia L; Boczkowski J
    Pharmacol Ther; 2015 Sep; 153():125-34. PubMed ID: 26096607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries.
    Takahashi S; Betsuyaku T
    Respir Investig; 2015 Nov; 53(6):259-70. PubMed ID: 26521103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease.
    Aoshiba K; Nagai A
    Proc Am Thorac Soc; 2009 Dec; 6(7):596-601. PubMed ID: 19934355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescence-associated secretory phenotype and its possible role in chronic obstructive pulmonary disease.
    Kumar M; Seeger W; Voswinckel R
    Am J Respir Cell Mol Biol; 2014 Sep; 51(3):323-33. PubMed ID: 25171460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease.
    Zhao CZ; Fang XC; Wang D; Tang FD; Wang XD
    Respir Med; 2010 Oct; 104(10):1391-5. PubMed ID: 20638828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD).
    MacNee W
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):819-23. PubMed ID: 19614601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects on pathophysiological mechanisms in COPD.
    Larsson K
    J Intern Med; 2007 Sep; 262(3):311-40. PubMed ID: 17697154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease and comorbidity: a review and consideration of pathophysiology.
    Tan SL; Wood AM
    Panminerva Med; 2009 Jun; 51(2):81-93. PubMed ID: 19776710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Chronic Obstructive Pulmonary Disease an Accelerated Aging Disease?
    MacNee W
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S429-S437. PubMed ID: 28005421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytokines and proteases involved in pathogenesis of COPD].
    Yamaya A; Osanai K
    Nihon Rinsho; 2011 Oct; 69(10):1748-53. PubMed ID: 22073567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of inflammation in the etiopathogenesis of COPD].
    del Puerto-Nevado L; Pérez-Rial S; Girón-Martínez A; Peces-Barba G
    Arch Bronconeumol; 2010 Dec; 46 Suppl 11():2-7. PubMed ID: 21316554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunopathology of chronic obstructive pulmonary disease].
    Martínez-Aguilar NE; Vargas-Camaño ME; Hernández-Pliego RR; Chaia-Semerena GM; Pérez-Chavira MR
    Rev Alerg Mex; 2017; 64(3):327-346. PubMed ID: 29046030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease.
    Tsuji T; Aoshiba K; Nagai A
    Respiration; 2010; 80(1):59-70. PubMed ID: 20016134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.
    McNicholas WT
    Am J Respir Crit Care Med; 2009 Oct; 180(8):692-700. PubMed ID: 19628778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.